While the exact dose-response relationship for these effects is less clearly established than for GI symptoms, clinical pharmacology suggests that any side effect mediated by GLP-1 and GIP receptor activation could intensify with higher drug exposure
AM833 has also been evaluated for use in combination with the GLP-1 analogue semaglutide in a phase I clinical trial (124, 141)
Limited time only
Combining GLP-1 receptor agonists (GLP-1 RAs) with Metformin has shown promising results for women with PCOS, especially in tackling weight management and improving both metabolic and reproductive health
The 4 patient group inputs reported that overweight and obesity affect many areas of life and patients usually present with various comorbid conditions, such as arthritis, hypertension, sleep apnea, gastroesophageal reflux disease, irritable bowel syndrome, high cholesterol, diabetes, fatty liver disease, asthma, osteoarthritis, infertility, cancers, and mental health issues
Taking symlin can reduce the amount of insulin you need to take
